Real-time enrollment status for this paroxysmal nocturnal hemoglobinuria clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:13 PM UTC
| NCT Number | NCT06411626 |
| Recruiting Status | Recruiting |
| Condition | Paroxysmal Nocturnal Hemoglobinuria |
| Phase | Clinical Trial |
| Target Enrollment | 128 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | August 27, 2025 (Aug 27, 2025) |
As of July 13, 2026: Clinical trial NCT06411626 is currently recruiting participants. This clinical trial study for paroxysmal nocturnal hemoglobinuria is actively seeking new participants at 1 location across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06411626 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06411626 was last updated Aug 27, 2025 (August 27, 2025). HelloStudys verifies this status automatically.